{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T23:33:04Z","timestamp":1771716784925,"version":"3.50.1"},"reference-count":49,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T00:00:00Z","timestamp":1655769600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"},{"start":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T00:00:00Z","timestamp":1655769600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T00:00:00Z","timestamp":1655769600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,10,26]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Transitory appearance of immune suppressive polymorphonuclear neutrophils (PMNs) defined as myeloid-derived suppressor cells (PMNs-MDSCs) in newborns is important for their protection from inflammation associated with newly established gut microbiota. Here, we report that inhibition of the type I IFN (IFN1) pathway played a major role in regulation of PMNs-MDSCs-suppressive activity during first weeks of life. Expression of the IFN1 receptor IFNAR1 was markedly lower in PMNs-MDSCs. However, in newborn mice, down-regulation of IFNAR1 was not sufficient to render PMNs immune suppressive. That also required the presence of a positive signal from lactoferrin via its receptor low-density lipoprotein receptor-related protein 2. The latter effect was mediated via NF-\u03baB activation, which was tempered by IFN1 in a manner that involved suppressor of cytokine signaling 3. Thus, we discovered a mechanism of tight regulation of immune suppressive PMNs-MDSCs in newborns, which may be used in the development of therapies of neonatal pathologies.<\/jats:p>","DOI":"10.1002\/jlb.4hi0921-514rr","type":"journal-article","created":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T11:31:47Z","timestamp":1655811107000},"page":"955-968","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Mechanisms regulating transitory suppressive activity of neutrophils in newborns: PMNs-MDSCs in newborns"],"prefix":"10.1093","volume":"112","author":[{"given":"Michela","family":"Perego","sequence":"first","affiliation":[{"name":"The Wistar Institute , Philadelphia, Pennsylvania, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuyu","family":"Fu","sequence":"additional","affiliation":[{"name":"The Wistar Institute , Philadelphia, Pennsylvania, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingjiao","family":"Cao","sequence":"additional","affiliation":[{"name":"Key Laboratory of Immune Microenvironment and Disease of the Ministry of Education, Department of Immunology, School of Basic Sciences, Tianjin Medical University , Tianjin, China"},{"name":"Zhongshan School of Medicine, Sun Yat-sen University , Guangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Kossenkov","sequence":"additional","affiliation":[{"name":"The Wistar Institute , Philadelphia, Pennsylvania, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng","family":"Yao","sequence":"additional","affiliation":[{"name":"Key Laboratory of Immune Microenvironment and Disease of the Ministry of Education, Department of Immunology, School of Basic Sciences, Tianjin Medical University , Tianjin, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin","family":"Bonner","sequence":"additional","affiliation":[{"name":"The Wistar Institute , Philadelphia, Pennsylvania, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Alicea-Torres","sequence":"additional","affiliation":[{"name":"The Wistar Institute , Philadelphia, Pennsylvania, USA"},{"name":"Biology Department, University of Puerto Rico-Humacao , Humacao, Puerto Rico, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wangkai","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, First Affiliated Hospital, Sun Yat-sen University , Guangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhilong","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Zhongshan Hospital; Shanghai Institute of Respiratory Disease, Fudan University , Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhihong","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Zhongshan Hospital; Shanghai Institute of Respiratory Disease, Fudan University , Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serge Y","family":"Fuchs","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, School of Veterinary Medicine University of Pennsylvania , Philadelphia, Pennsylvania, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Zhou","sequence":"additional","affiliation":[{"name":"Key Laboratory of Immune Microenvironment and Disease of the Ministry of Education, Department of Immunology, School of Basic Sciences, Tianjin Medical University , Tianjin, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dmitry I","family":"Gabrilovich","sequence":"additional","affiliation":[{"name":"AstraZeneca , Gaithersburg, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2022,6,21]]},"reference":[{"key":"2023032107471033600_","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/s41590-017-0022-x","article-title":"Myeloid-derived suppressor cells coming of age","volume":"19","author":"Veglia","year":"2018","journal-title":"Nat Immunol"},{"key":"2023032107471033600_","doi-asserted-by":"crossref","first-page":"e107816","DOI":"10.1371\/journal.pone.0107816","article-title":"Myeloid derived suppressor cells are present at high frequency in neonates and suppress in vitro T cell responses","volume":"9","author":"Gervassi","year":"2014","journal-title":"PLoS One"},{"key":"2023032107471033600_","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/cei.12143","article-title":"Neutrophilic myeloid-derived suppressor cells in cord blood modulate innate and adaptive immune responses","volume":"174","author":"Rieber","year":"2013","journal-title":"Clinical and Experimental Immunology"},{"key":"2023032107471033600_","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/cei.13059","article-title":"Granulocytic myeloid-derived suppressor cells (GR-MDSC) accumulate in cord blood of preterm infants and remain elevated during the neonatal period","volume":"191","author":"Schwarz","year":"2018","journal-title":"Clinical and Experimental Immunology"},{"key":"2023032107471033600_","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/imcb.12224","article-title":"Murine myeloid-derived suppressor cells are a source of elevated levels of interleukin-27 in early life and compromise control of bacterial infection","volume":"97","author":"Parson","year":"2019","journal-title":"Immunol Cell Biol"},{"key":"2023032107471033600_","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/imm.12751","article-title":"Granulocytic myeloid-derived suppressor cells from human cord blood modulate T-helper cell response towards an anti-inflammatory phenotype","volume":"152","author":"Kostlin","year":"2017","journal-title":"Immunology"},{"key":"2023032107471033600_","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1096\/fj.201601083R","article-title":"In neonates S100A8\/S100A9 alarmins prevent the expansion of a specific inflammatory monocyte population promoting septic shock","volume":"31","author":"Heinemann","year":"2017","journal-title":"FASEB J"},{"key":"2023032107471033600_","first-page":"22","article-title":"Myeloid-derived suppressor cells gain suppressive function during neonatal bacterial sepsis","volume-title":"International Journal of Molecular Sciences","author":"Vance","year":"2021"},{"key":"2023032107471033600_","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/nm.4467","article-title":"Transitory presence of myeloid-derived suppressor cells in neonates is critical for control of inflammation","volume":"24","author":"He","year":"2018","journal-title":"Nat Med"},{"key":"2023032107471033600_","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.immuni.2009.08.009","article-title":"Immune responses to the microbiota at the intestinal mucosal surface","volume":"31","author":"Duerkop","year":"2009","journal-title":"Immunity"},{"key":"2023032107471033600_","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1172\/JCI128164","article-title":"Lactoferrin-induced myeloid-derived suppressor cell therapy attenuates pathologic inflammatory conditions in newborn mice","volume":"129","author":"Liu","year":"2019","journal-title":"J Clin Invest"},{"key":"2023032107471033600_","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ccell.2018.12.001","article-title":"An interferon-driven oxysterol-based defense against tumor-derived extracellular vesicles","volume":"35","author":"Ortiz","year":"2019","journal-title":"Cancer Cell"},{"key":"2023032107471033600_","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/s12931-017-0707-6","article-title":"Lack of SOCS3 increases LPS-induced murine acute lung injury through modulation of Ly6C(+) macrophages","volume":"18","author":"Jiang","year":"2017","journal-title":"Respiratory Research"},{"key":"2023032107471033600_","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nmeth.1923","article-title":"Fast gapped-read alignment with Bowtie 2","volume":"9","author":"Langmead","year":"2012","journal-title":"Nat Methods"},{"key":"2023032107471033600_","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1186\/1471-2105-12-323","article-title":"RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome","volume":"12","author":"Li","year":"2011","journal-title":"BMC Bioinformatics"},{"key":"2023032107471033600_","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biology"},{"key":"2023032107471033600_","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1038\/s41467-021-22033-2","article-title":"Immune suppressive activity of myeloid-derived suppressor cells in cancer requires inactivation of the type I interferon pathway","volume":"12","author":"Alicea-Torres","year":"2021","journal-title":"Nature Communications"},{"key":"2023032107471033600_","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nri1604","article-title":"Mechanisms of type-I- and type-II-interferon-mediated signalling","volume":"5","author":"Platanias","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"2023032107471033600_","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nri3845","article-title":"Type I interferons in anticancer immunity","volume":"15","author":"Zitvogel","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"2023032107471033600_","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1084\/jem.20101664","article-title":"Type I interferon: friend or foe?","volume":"207","author":"Trinchieri","year":"2010","journal-title":"J Exp Med"},{"key":"2023032107471033600_","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1089\/jir.2012.0117","article-title":"Hope and fear for interferon: the receptor-centric outlook on the future of interferon therapy","volume":"33","author":"Fuchs","year":"2013","journal-title":"J Interferon Cytokine Res"},{"key":"2023032107471033600_","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.it.2015.01.002","article-title":"The molecular basis for functional plasticity in type I interferon signaling","volume":"36","author":"Schreiber","year":"2015","journal-title":"Trends Immunol"},{"key":"2023032107471033600_","doi-asserted-by":"crossref","first-page":"46614","DOI":"10.1074\/jbc.M407082200","article-title":"Phosphorylation and specific ubiquitin acceptor sites are required for ubiquitination and degradation of the IFNAR1 subunit of type I interferon receptor","volume":"279","author":"Kumar","year":"2004","journal-title":"J Biol Chem"},{"key":"2023032107471033600_","doi-asserted-by":"crossref","first-page":"5480","DOI":"10.1093\/emboj\/cdg524","article-title":"SCF(HOS) ubiquitin ligase mediates the ligand-induced down-regulation of the interferon-alpha receptor","volume":"22","author":"Kumar","year":"2003","journal-title":"The EMBO Journal"},{"key":"2023032107471033600_","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/emmm.201303236","article-title":"Triggering ubiquitination of IFNAR1 protects tissues from inflammatory injury","volume":"6","author":"Bhattacharya","year":"2014","journal-title":"EMBO Mol Med"},{"key":"2023032107471033600_","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.celrep.2019.05.105","article-title":"Microbiota-driven tonic interferon signals in lung stromal cells protect from influenza virus infection","volume":"28","author":"Bradley","year":"2019","journal-title":"Cell Reports"},{"key":"2023032107471033600_","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.4049\/jimmunol.1900912","article-title":"Age-dependent effects of type I and type III IFNs in the pathogenesis of Bordetella pertussis infection and disease","volume":"204","author":"Ardanuy","year":"2020","journal-title":"J Immunol"},{"key":"2023032107471033600_","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/nrgastro.2016.119","article-title":"Necrotizing enterocolitis: new insights into pathogenesis and mechanisms","volume":"13","author":"Ni\u00f1o","year":"2016","journal-title":"Nat Rev Gastroneterol Hepatol"},{"key":"2023032107471033600_","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1056\/NEJMra1005408","article-title":"Necrotizing enterocolitis","volume":"364","author":"Neu","year":"2011","journal-title":"N Engl J Med"},{"key":"2023032107471033600_","doi-asserted-by":"crossref","first-page":"e16794","DOI":"10.1371\/journal.pone.0016794","article-title":"Megalin\/LRP2 expression is induced by peroxisome proliferator-activated receptor -alpha and -gamma: implications for PPARs' roles in renal function","volume":"6","author":"Cabezas","year":"2011","journal-title":"PLoS One"},{"key":"2023032107471033600_","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1038\/s41467-019-08794-x","article-title":"Dynamic molecular changes during the first week of human life follow a robust developmental trajectory","volume":"10","author":"Lee","year":"2019","journal-title":"Nature Communications"},{"key":"2023032107471033600_","doi-asserted-by":"crossref","first-page":"13631","DOI":"10.1073\/pnas.250477397","article-title":"IFNalpha\/beta promotes cell survival by activating NF-kappa B","volume":"97","author":"Yang","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"2023032107471033600_","doi-asserted-by":"crossref","first-page":"13756","DOI":"10.1074\/jbc.M011006200","article-title":"Interferon alpha \/beta promotes cell survival by activating nuclear factor kappa B through phosphatidylinositol 3-kinase and Akt","volume":"276","author":"Yang","year":"2001","journal-title":"J Biol Chem"},{"key":"2023032107471033600_","doi-asserted-by":"crossref","first-page":"4927","DOI":"10.4049\/jimmunol.165.9.4927","article-title":"IFN-alpha suppresses activation of nuclear transcription factors NF-kappa B and activator protein 1 and potentiates TNF-induced apoptosis","volume":"165","author":"Manna","year":"2000","journal-title":"J Immunol"},{"key":"2023032107471033600_","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1084\/jem.20051725","article-title":"Twist mediates suppression of inflammation by type I IFNs and Axl","volume":"203","author":"Sharif","year":"2006","journal-title":"J Exp Med"},{"key":"2023032107471033600_","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1096\/fj.10-170597","article-title":"Suppressor of cytokine signaling 1 (SOCS1) limits NFkappaB signaling by decreasing p65 stability within the cell nucleus","volume":"25","author":"Strebovsky","year":"2011","journal-title":"FASEB J"},{"key":"2023032107471033600_","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3389\/fmicb.2019.00114","article-title":"Suppressor of cytokine signaling 3 (SOCS3) degrades p65 and regulate HIV-1 replication","volume":"10","author":"Sood","year":"2019","journal-title":"Front Microbiol"},{"key":"2023032107471033600_","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/1471-2407-10-142","article-title":"Modulation of SOCS protein expression influences the interferon responsiveness of human melanoma cells","volume":"10","author":"Lesinski","year":"2010","journal-title":"BMC Cancer"},{"key":"2023032107471033600_","doi-asserted-by":"crossref","first-page":"4832","DOI":"10.4049\/jimmunol.178.8.4832","article-title":"IFN-alpha-induced signal transduction, gene expression, and antitumor activity of immune effector cells are negatively regulated by suppressor of cytokine signaling proteins","volume":"178","author":"Zimmerer","year":"2007","journal-title":"J Immunol"},{"key":"2023032107471033600_","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1055\/s-0032-1333412","article-title":"Role of innate immunity in neonatal infection","volume":"30","author":"Cuenca","year":"2013","journal-title":"American Journal of Perinatology"},{"key":"2023032107471033600_","doi-asserted-by":"crossref","first-page":"190128","DOI":"10.1098\/rsob.190128","article-title":"Temporal development of the infant gut microbiome","volume":"9","author":"Moore","year":"2019","journal-title":"Open Biol"},{"key":"2023032107471033600_","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.3389\/fmicb.2016.01523","article-title":"Monitoring perinatal gut microbiota in mouse models by mass spectrometry approaches: parental genetic background and breastfeeding effects","volume":"7","author":"Levi Mortera","year":"2016","journal-title":"Front Microbiol"},{"key":"2023032107471033600_","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.3389\/fimmu.2017.01438","article-title":"Lactoferrin in a context of inflammation-induced pathology","volume":"8","author":"Kruzel","year":"2017","journal-title":"Frontiers in Immunology"},{"key":"2023032107471033600_","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.chom.2013.04.015","article-title":"Crosstalk between the type 1 interferon and nuclear factor kappa B pathways confers resistance to a lethal virus infection","volume":"13","author":"Rubio","year":"2013","journal-title":"Cell Host Microbe"},{"key":"2023032107471033600_","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1126\/science.aam5336","article-title":"The microbial metabolite desaminotyrosine protects from influenza through type I interferon","volume":"357","author":"Steed","year":"2017","journal-title":"Science"},{"key":"2023032107471033600_","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.immuni.2018.03.003","article-title":"Loss of NF-kappaB1 causes gastric cancer with aberrant inflammation and expression of immune checkpoint regulators in a STAT-1-dependent manner","volume":"48","author":"O'Reilly","year":"2018","journal-title":"Immunity"},{"key":"2023032107471033600_","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.tibs.2008.12.003","article-title":"Autoregulatory feedback loops terminating the NF-kappaB response","volume":"34","author":"Renner","year":"2009","journal-title":"Trends in Biochemical Sciences"},{"key":"2023032107471033600_","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1074\/jbc.R300030200","article-title":"Inhibitors of cytokine signal transduction","volume":"279","author":"Wormald","year":"2004","journal-title":"J Biol Chem"},{"key":"2023032107471033600_","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nri3581","article-title":"Regulation of type I interferon responses","volume":"14","author":"Ivashkiv","year":"2014","journal-title":"Nat Rev Immunol"}],"container-title":["Journal of Leukocyte Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/JLB.4HI0921-514RR","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/JLB.4HI0921-514RR","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jleukbio\/article-pdf\/112\/5\/955\/49470471\/jlb11180.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jleukbio\/article-pdf\/112\/5\/955\/49470471\/jlb11180.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T13:46:09Z","timestamp":1700747169000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jleukbio\/article\/112\/5\/955\/6976266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,21]]},"references-count":49,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,6,21]]},"published-print":{"date-parts":[[2022,10,26]]}},"URL":"https:\/\/doi.org\/10.1002\/jlb.4hi0921-514rr","relation":{},"ISSN":["0741-5400","1938-3673"],"issn-type":[{"value":"0741-5400","type":"print"},{"value":"1938-3673","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,11]]},"published":{"date-parts":[[2022,6,21]]},"assertion":[{"value":"2021-09-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-28","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-21","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}